Holen Sie sich die Stockscreener-App
0.00
100.00%
-4.02
Nanovibronix Inc Aktie (NAOV) Neueste Nachrichten
Nanovibronix (NASDAQ:FEED) Upgraded by Wall Street Zen to Hold Rating - Defense World
Is NanoVibronix Inc. stock a defensive play in 2025Weekly Investment Recap & High Accuracy Swing Trade Signals - mfd.ru
Head-To-Head Review: Nanovibronix (FEED) versus The Competition - Defense World
Analyzing Nanovibronix (FEED) & Its Competitors - Defense World
Nanovibronix (FEED) & Its Competitors Financial Comparison - Defense World
Analyst Upgrade: Is NanoVibronix Inc a potential multi baggerWeekly Trading Summary & Real-Time Price Movement Reports - baoquankhu1.vn
Fundamentals Check: Is McCormick Company Incorporated gaining market share2025 Momentum Check & Consistent Return Strategy Ideas - baoquankhu1.vn
Nanovibronix (FEED) & Its Competitors Head to Head Review - Defense World
Head to Head Analysis: Nanovibronix (FEED) vs. Its Competitors - Defense World
Contrasting Nanovibronix (NASDAQ:FEED) and Biosig Technologies (NASDAQ:STEX) - Defense World
Financial Survey: TransEnterix (OTCMKTS:TRXDW) versus Nanovibronix (NASDAQ:FEED) - Defense World
Is NanoVibronix Inc. stock affected by interest rate hikesAnalyst Upgrade & Verified Technical Signals - mfd.ru
Will NanoVibronix Inc. (56R) stock profit from fiscal stimulus2025 Price Momentum & Weekly Stock Breakout Alerts - mfd.ru
Can NanoVibronix Inc. generate free cash flow2025 Risk Factors & High Accuracy Swing Trade Signals - mfd.ru
Is NanoVibronix Inc. a potential multi bagger2025 Key Lessons & Real-Time Buy Signal Notifications - mfd.ru
Will NanoVibronix Inc. be affected by tariffs2025 Top Decliners & Real-Time Price Movement Reports - mfd.ru
Is NanoVibronix Inc. stock overvalued by current metricsLong Setup & Short-Term Trading Opportunity Alerts - mfd.ru
Is NanoVibronix Inc. subject to activist investor interest2025 Earnings Impact & Advanced Swing Trade Entry Alerts - mfd.ru
Targets Report: What are the future prospects of Arlo Technologies Inc2025 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
MACD Signal: What makes NanoVibronix Inc stock attractive todayAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Envue Medical: Bank of America sells $8.9k in stock By Investing.com - Investing.com UK
Envue Medical: Bank of America sells $8.9k in stock - Investing.com
Top Small Cap Stocks To Keep An Eye OnJanuary 29th - MarketBeat
Manufacturing Stocks To ResearchJanuary 29th - MarketBeat
Stop Loss: Is ACCS trading at a discount2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
ENvue Medical skyrockets on reusable feeding tube syringe distribution deal - Mugglehead Investment Magazine
ENvue Medical partners with U-Deliver to distribute ENFit syringes By Investing.com - Investing.com Nigeria
Why Is FEED Stock Soaring Over 130% Today? - Asianet Newsable
ENvue Medical Appoints New VP to Boost Enteral Platform Expansion - StocksToTrade
ENvue Medical partners with U-Deliver to distribute ENFit syringes - Investing.com
EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal - Benzinga
Targets Report: Is Groupon Inc in a bullish channel2025 Investor Takeaways & AI Forecast Swing Trade Picks - baoquankhu1.vn
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial - Sahm
IPO Launch: Is NanoVibronix Inc a potential multi baggerJuly 2025 Update & Expert-Curated Trade Recommendations - baoquankhu1.vn
Targets Report: How does SGMO perform in inflationary periods2025 Top Decliners & Target Return Focused Picks - baoquankhu1.vn
Aug Update: Can OXYWS disrupt its industryJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Market Pulse: Is NanoVibronix Inc stock showing strong momentum2025 Sector Review & Daily Stock Trend Reports - baoquankhu1.vn
Can NanoVibronix Inc. stock sustain revenue growth2025 Risk Factors & Breakout Confirmation Trade Signals - Улправда
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research - The Manila Times
ENvue Medical Launches Program to Address Patient Pain and - GlobeNewswire
New program targets pain from nasogastric tubes left in for days - Stock Titan
Why NanoVibronix Inc. stock is seen as undervaluedJuly 2025 Momentum & AI Based Buy and Sell Signals - Улправда
Why NanoVibronix Inc. stock could outperform in 2025July 2025 Recap & Trade Opportunity Analysis Reports - Улправда
Is NanoVibronix Inc. (56R) stock a top pick for value investors2025 Performance Recap & Free Community Consensus Stock Picks - ulpravda.ru
Can NanoVibronix Inc. (56R) stock deliver strong annual returns2025 Short Interest & Community Verified Watchlist Alerts - Улправда
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 - GlobeNewswire
How analysts revise price targets for NanoVibronix Inc. (56R) stockJuly 2025 Levels & Fast Entry and Exit Trade Plans - Улправда
Will NanoVibronix Inc. (56R) stock beat international competitionHigh Beta Stocks & Invest Now – Opportunity Window Closing - Улправда
Envue Medical amends long term incentive plan to align with Israeli tax laws - Investing.com
ENvue Medical, Inc.Common Stock (NQ: NAOV - FinancialContent
Short Covering: Will NanoVibronix Inc stock continue dividend increases2025 Winners & Losers & High Conviction Buy Zone Alerts - moha.gov.vn
Market Outlook: Is CANF stock a top momentum playTrade Exit Summary & Daily Chart Pattern Signals - moha.gov.vn
Can NanoVibronix Inc. stock hit analyst price targets2025 Institutional Moves & Technical Pattern Recognition Alerts - Улправда
Will NanoVibronix Inc. stock continue dividend increases2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - Bölüm Sonu Canavarı
Decliners Report: Is NanoVibronix Inc. stock a dividend growth opportunity2025 Stock Rankings & Entry Point Confirmation Alerts - moha.gov.vn
Why NanoVibronix Inc. stock appeals to analystsTreasury Yields & Technical Entry and Exit Alerts - Улправда
0.50%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):